Belite Bio, Inc. ADR (BLTE) Stock Research

Today

Belite Bio announces FDA acceptance, priority review of tinlarebant NDA

BLTE

4:40 PM

Over a week ago

Belite Bio completes rolling submission of NDA to U.S. FDA for tinlarebant

BLTE

Jun 14, 4:26 PM

Belite Bio price target lowered by $8 at Mizuho, here's why

BLTE

May 26, 8:19 AM

Belite Bio reports Q1 non-GAAP EPS (34c), consensus (64c)

BLTE

May 20, 6:08 AM

Belite Bio receives orphan drug status for tinlarebant in Switzerland

BLTE

May 18, 4:04 PM

Belite Bio management to meet wit Cantor

BLTE

Apr 29, 5:14 PM

Belite Bio initiates rolling submission of NDA to U.S FDA for tinlarebant

BLTE

Apr 21, 4:03 PM

Belite Bio price target raised by $15 at H.C. Wainwright, here's why

BLTE

Mar 3, 12:16 PM

Belite Bio price target raised by $30 at Benchmark, here's why

BLTE

Mar 3, 8:22 AM

Belite Bio price target raised by $66 at Cantor Fitzgerald, here's why

BLTE

Mar 3, 8:17 AM

Belite Bio price target raised by $10 at Morgan Stanley, here's why

BLTE

Mar 3, 8:11 AM

Belite Bio price target raised by $5 at BofA, here's why

BLTE

Mar 3, 6:37 AM

What You Missed On Wall Street On Monday

+34

Mar 2, 4:17 PM

Midday Fly By: Markets bounce back following U.S.-Israeli attacks on Iran

+34

Mar 2, 12:01 PM

Belite Bio sees FY25 adjusted EPS ($1.15) vs. ($89c) last year

BLTE

Mar 2, 6:11 AM

Belite Bio sees Q4 adjusted EPS (38c), consensus (54c)

BLTE

Mar 2, 6:10 AM

Belite Bio price target raised by $29 at Mizuho

BLTE

Feb 19, 7:17 AM

Belite Bio completes enrollment in DRAGON II trial of tinlarebant

BLTE

Jan 27, 8:06 AM

Netflix, Meta upgraded: Wall Street's top analyst calls

+13

Jan 26, 9:50 AM

Belite Bio initiated with bullish view at BofA, here's why

BLTE

Jan 26, 6:28 AM

Belite Bio initiated with bullish view at Morgan Stanley, here's why

BLTE

Jan 6, 5:00 AM

Belite Bio participates in a conference call with H.C. Wainwright

BLTE

Dec 17, 1:43 PM

Belite Bio price target raised by $60 at Maxim, here's why

BLTE

Dec 2, 3:05 PM

Belite Bio 2.273M share Spot Secondary priced at $154.00

BLTE

Dec 2, 6:24 AM